Zobrazeno 1 - 10
of 172
pro vyhledávání: '"F. Wares"'
Autor:
D F Wares, M Mbenga, V Mirtskhulava, M Quelapio, A Slyzkyi, I Koppelaar, S N Cho, U Go, J S Lee, J-K Jung, D Everitt, S Foraida, M Diachenko, S Juneja, E Burhan, A Totkogonova, Z Myint, I Flores, N A Lytvynenko, N Parpieva, N V Nhung, A Gebhard
Publikováno v:
PLoS ONE, Vol 19, Iss 11, p e0310773 (2024)
BackgroundPreviously, drug-resistant tuberculosis (DR-TB) patients were treated with long, toxic, and relatively ineffective regimens. However, in recent years, there have been major improvements made. The 2020 World Health Organization DR-TB Treatme
Externí odkaz:
https://doaj.org/article/40b4b622ea5845869a0f2bee9ec4d0e1
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 26:524-528
BACKGROUND: The continued development of new anti-TB agents brings with it a demand for accompanying treatment regimens to prevent the development of resistance. Effectively meeting this demand requires an understanding of the pathogen´s susceptibil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8978b4a427a5fb7785851f6ca77f6ee2
https://doi.org/10.5588/ijtld.21.0420
https://doi.org/10.5588/ijtld.21.0420
Autor:
C G Edwards, K van Weezenbeek, D F Wares, Edine W. Tiemersma, A Gebhard, G Dravniece, E van der Grinten, M Gidado
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 24:1046-1053
BACKGROUND: Drug-resistant tuberculosis (DR-TB) remains a global public health crisis. In 2013, the World Health Organization recommended the introduction of bedaquiline (BDQ) for eligible DR-TB patients.METHODS: We conducted a retrospective review a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24965d781f157d6a2b5cddaf65b5a696
https://doi.org/10.5588/ijtld.19.0790
https://doi.org/10.5588/ijtld.19.0790
Publikováno v:
Public Health Action
Previous and current patients with drug-resistant TB (DR-TB) who had documented treatment-related hearing impairment due to second-line injectable (SLI) use were identified from different DR-TB treatment initiation centres in Ethiopia.To assess selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2cf10aaac899b1f04cfd5c1f4120ccd1
https://pubmed.ncbi.nlm.nih.gov/35734010
https://pubmed.ncbi.nlm.nih.gov/35734010
Autor:
A. Kassa, E. Tesema, A. Bedru, D. Gemechu, Y. Molla, F. Tsegaye, F. Wares, L. Taye, C. Negeri
Publikováno v:
Public Health Action
Drug-resistant TB (DR-TB) remains a major public health concern. DR-TB patient data from ALERT (All Africa Leprosy, Tuberculosis and Rehabilitation Training Centre) Hospital, Addis Ababa, Ethiopia, who received bedaquiline (BDQ) and/or delamanid (DLM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283832109a23699b8ef7a9ed5fa8e7f8
https://europepmc.org/articles/PMC8202633/
https://europepmc.org/articles/PMC8202633/
Autor:
Peter Cegielski, Paul Nunn, Ekaterina V. Kurbatova, Karin Weyer, Tracy L. Dalton, Douglas F. Wares, Michael F. Iademarco, Kenneth G. Castro, Mario Raviglione
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 11, Pp - (2012)
In March 2012, in response to reports of tuberculosis (TB) resistant to all anti-TB drugs, the World Health Organization convened an expert consultation that identified issues to be resolved before defining a new category of highly drug-resistant TB.
Externí odkaz:
https://doaj.org/article/5055790cd0bf4e73b3d3d59a1f9fe421
Publikováno v:
Indian Journal of Tuberculosis. 64:40-43
Smoking and alcohol consumption are important risk factors for pulmonary tuberculosis (PTB). A cross-sectional survey was undertaken among the Gond tribe in Jabalpur district of Madhya Pradesh, and information on smoking and alcohol consumption was c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e002979e8c54a421152b227e7dbea4
https://doi.org/10.1016/j.ijtb.2016.11.009
https://doi.org/10.1016/j.ijtb.2016.11.009
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 23:378-379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d1aa2688a247ddf7ebc643342345205
https://doi.org/10.5588/ijtld.18.0558
https://doi.org/10.5588/ijtld.18.0558
Publikováno v:
Indian Journal of Tuberculosis. 62:121-123
A cross-sectional tuberculosis prevalence survey was undertaken in Jabalpur district, Madhya Pradesh, central India. All individuals were questioned for chest symptoms. Sputum samples were collected and examined for microscopy and culture. Overall pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54004538c4ceb2d34e762cf72f567afe
https://doi.org/10.1016/j.ijtb.2015.04.012
https://doi.org/10.1016/j.ijtb.2015.04.012
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 17:1257-1266
Although cycloserine (CS) is recommended by the World Health Organization as a second-line agent for the treatment of multidrug-resistant tuberculosis (MDR-TB), safety concerns have impeded its uptake by several national TB programmes. Terizidone (TR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67e237aa473d79dc49c9a5554aa98a14
https://doi.org/10.5588/ijtld.12.0863
https://doi.org/10.5588/ijtld.12.0863